Rockville, MD (PRWEB) October 12, 2010
CME Outfitters, LLC, (CMEO) an award-winning accredited provider of multidisciplinary continuing education (CE), in co-sponsorship with USF Health, is pleased to announce an upcoming interactive, evidence-based neuroscienceCME Live and On Demand continuing education activity titled "Early Identification, Intervention, and Quality Care in Schizophrenia: Bringing Together Community, Family, and Physicians."
Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, November 3, 2010, from 12:00 p.m.-1:00 p.m. ET, the activity seeks to provide clinicians with an update on the best practices for identifying and managing individuals with schizophrenia utilizing a multimodal treatment plan which includes medication, adherence to treatment, psychosocial interventions, and the involvement of family and other significant people in a patient’s care. This activity also includes a special "After the Show" segment from 1:00 p.m.-1:30 p.m. ET during which the faculty answers additional audience questions in an informal Q&A session. The recorded webcast will re-air from 4:00 p.m.-5:00 p.m. ET. This CE activity will also be available on demand as a webcast, podcast, and telephone audioconference shortly after the broadcast premiere.
There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www.neuroscienceCME.com/PR512 and click the Register for Live Webcast icon.
Phone: Call 877.CME.PROS (877.263.7767).
Fax: Visit the activity details page at http://www.neuroscienceCME.com/PR512, print and complete the activity details form, and fax to 614.929.3600.
Statement of Need:
Schizophrenia is a disease that begins in early adulthood and places a significant burden on the family and on society. Early identification and treatment that involves collaboration among families, care providers, and the community have been shown to be effective. Treatment that includes pharmacotherapy, psychotherapy, and psychosocial intervention has been shown to reduce the risk of early transition into psychosis in young people who are at risk. Clinicians can make a significant and often lifelong impact if they understand which individuals are at risk and recognize the prodromal symptoms of schizophrenia. Clinicians need to develop a multimodal, collaborative treatment plan for the care of individuals with schizophrenia or early signs of psychosis. Knowledge of standardized, validated assessment tools can assist the clinician in screening for side effects and adherence to treatment. In this neuroscienceCME Live and On Demand, the experts will provide clinically relevant practice points for the early identification and clinical management of schizophrenia.
Jeffrey A. Lieberman, MD (Moderator)
Chairman, Department of Psychiatry
College of Physicians and Surgeons, Columbia University
Director, New York State Psychiatric Institute
Director, Lieber Center for Schizophrenia Research
Psychiatrist-in-Chief at New York Presbyterian Hospital & Columbia University Medical Center
New York, NY
Lisa Dixon, MD, MPH
Professor, University of Maryland School of Medicine
Director, Division of Health Services Research
VA Capitol Health Care Network MIRECC
John W. Newcomer, MD
Gregory B. Couch Professor of Psychiatry, Psychology and Medicine
Director, Clinical Trials Unit, Institute of Clinical and Translational Sciences (ICTS)
Director, Regulatory Support Center, ICTS
Medical Director, Center for Clinical Studies
Washington University School of Medicine
St. Louis, MO
At the end of this CE activity, participants should be able to:
- Identify signs and symptoms of prodromal and first-episode psychosis that typically would be seen and could be recognized by both primary care physicians and psychiatrists.
- Customize a medication plan for patients with schizophrenia that uses a structured screening tool to detect lack of adherence and considers tolerability and ease of administration.
- Design a multimodal, individualized treatment and monitoring plan that specifies assessment tool, medication therapy, behavioral therapy, and follow-up regimen for patients with schizophrenia.
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, psychologists, social workers, certified case managers, and other health care professionals with an interest in managing patients with schizophrenia.
Supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
This activity offers CE credit for:
- Physicians (ACCME/AMA PRA Category 1™)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date: Thursday, November 3, 2011
Post-tests, credit request forms, and activity evaluations must be completed online at http://www.neuroscienceCME.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required).
USF Health adheres to the ACCME Standards regarding commercial support of continuing medical education. It is the policy of USF Health that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.
About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Clinical Compass™, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on "Subscribe to Clinical Compass™."
About USF Health (University of South Florida):
USF Health produces educational activities that are scientifically valid, free of commercial bias, and based on the principles of adult learning. These activities are developed around specific needs related to gaps in competence, performance, and/or patient outcomes, and, whenever possible, offer education delivered in settings best suited to the intended results.
Contact: Rachel Ellis
CME Outfitters, LLC